TipRanks

Sergio Traversa Insider Profile

11 Followers
Sergio Traversa, CEO, Director at Relmada Therapeutics, holds 1.50M shares in Relmada Therapeutics (Ticker: RLMD), holds 0.00 shares in Actinium Pharmaceuticals (Ticker: ATNM). Most recently, Sergio Traversa Bought ― shares of Relmada Therapeutics on Sep 11, 2026 for an estimated value of $828.00K.
tipranks
Sergio Traversa

Sergio Traversa
Relmada Therapeutics (RLMD)
CEO, Director

Ranked #448 out of 109,287 Corporate Insiders

Profitable Transactions

40%
4 out of 10 Profitable Transactions

Average Return

+110.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5M
100.00%
0.00%
A breakdown of Sergio Traversa's holdings

Insider Roles

Relmada Therapeutics
(RLMD)
CEO, Director
Actinium Pharmaceuticals
(ATNM)
Director
Roles that Sergio Traversa holds in companies

Most Profitable Insider Trade

Stock:
Relmada Therapeutics
(RLMD)
Rating:Informative Buy
Date:May 20, 2025 - May 20, 2026
Return:+800.00%
The most profitable trade made by Sergio Traversa

Sergio Traversa's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Relmada Therapeutics
Sep 11, 2026
CEO, Director
Informative Buy
828.00K
$4.82M
Actinium Pharmaceuticals
Apr 18, 2016
Director
Informative Buy
6.06K
$0.00
List of latest transactions for each holding click on a transaction to see Sergio Traversa's performance on stock

Sergio Traversa insider profile FAQ

What is the percentage of profitable transactions made by Sergio Traversa?
The percentage of profitable transactions made by Sergio Traversa is 40%.
    What is the average return per transaction made by Sergio Traversa?
    The average return per transaction made by Sergio Traversa is 110.60%.
      What stocks does Sergio Traversa hold?
      Sergio Traversa holds: RLMD, ATNM stocks.
        What was Sergio Traversa’s latest transaction?
        Sergio Traversa latest transaction was an Informative Buy of $828.00K.
          What was Sergio Traversa's most profitable transaction?
          Sergio Traversa’s most profitable transaction was an Informative Buy of RLMD stock on May 20, 2025. The return on the trade was 800.00%.
            What is Sergio Traversa's role in Relmada Therapeutics?
            Sergio Traversa's role in Relmada Therapeutics is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.